Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
738.50    -6.00 (-0.81%)
Bid:
736.00
Ask:
739.50
Spread: 3.50 (0.476%)
Market Cap: £2.48b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Updated expectations for full year 2022

6 Jul 2022 17:46

RNS Number : 5930R
Drax Group PLC
06 July 2022
Β 

6 July 2022

Β 

Drax Group plc

("Drax", "the Group", "Drax Group", "the Company"; Symbol: DRX)

Β 

Updated expectations for full year 2022

Β 

In response to increased pressure on European gas markets and associated concerns about electricity security of supply in the UK this winter, Drax continues to optimise its biomass generation and logistics. To accomplish this Drax is reprofiling biomass generation and supply from the summer to the winter, enabling it to provide high levels of reliable renewable electricity generation in the UK throughout the winter when demand is likely to be higher.

Β 

The Group also expects to provide additional support from pumped storage hydro at Cruachan Power Station, building on a strong year to date performance, which reflects a high level of system support activities.

Β 

Separately, at the request of the UK Government, Drax has now entered into an agreement with National Grid - in its capacity as the electricity systems operator - pursuant to which its two coal-fired units at Drax Power Station will remain available to provide a "winter contingency" service to the UK power system from October 2022 until the end of March 2023. The units will not generate commercially for the duration of the agreement and only operate if and when instructed to do so by National Grid.

Β 

Under the terms of the agreement, Drax will be paid a fee for the service and compensated for costs incurred, including coal costs, in connection with the operation of the coal units in accordance with the agreement.

Β 

Full year expectations

Reflecting these factors, Drax now expects that full year Adjusted EBITDA(1) for 2022 will be slightly above the top of the range of analyst expectations(2), subject to continued good operational performance.

Β 

Β 

Notes:

(1) Earnings before interest, tax, depreciation, amortisation, excluding the impact of exceptional items and certain remeasurements.

(2) As of 5 July 2022, analyst consensus for 2022 Adjusted EBITDA was Β£613 million, with a range of Β£584-Β£635 million. The details of this company collected consensus are displayed on the Group's website.

https://www.drax.com/investors/announcements-events-reports/presentations/

Β 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

Β 

Media:

Drax External Communications: Ali Lewis

+44 (0) 7712 670 888

Β 

Website: www.Drax.com

Β 

Β 

END

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTSSLFMMEESELW
Date   Source Headline
18th Jun 20267:00 amRNSClosure of Investigation by the FCA
17th Jun 20269:16 amRNSHolding(s) in Company
16th Jun 202610:00 amRNSDirector Declaration
5th Jun 202610:21 amRNSHolding(s) in Company
1st Jun 202611:02 amRNSIssue of Shares
1st Jun 202610:28 amRNSTotal Voting Rights
1st Jun 20267:47 amRNSDisclosure Table
1st Jun 20267:00 amRNSOffer for Bluefield Solar Income Fund Limited
29th May 20267:00 amRNSCommissioning of First OCGT Plant
27th May 20267:00 amRNSChief Financial Officer
26th May 20268:45 amRNSApplication for block admission to trading
8th May 20269:00 amRNSDirector/PDMR Shareholding
1st May 202610:15 amRNSTotal Voting Rights and Issue of Shares
30th Apr 202612:53 pmRNSResult of AGM
30th Apr 20267:00 amRNSTrading Update
15th Apr 20268:45 amRNSApplication for block admission to trading
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:46 pmRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 202612:09 pmRNSIssue of Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20269:48 amRNSNotice of AGM and Annual Report and Accounts
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 202610:35 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20264:43 pmRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSCapacity Market Agreements
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.